Imagine you're running a restaurant health inspection, but you only check restaurants whose owners voluntarily invite you in. The ones with roach problems probably aren't calling. That's been the CTE research problem for 15 years: brain banks only receive donated brains, and families who donate tend to suspect something was wrong. Every prior study showing 90%+ CTE rates in NFL brains came with a massive asterisk — selection bias. This Boston team tried to do the inspection on the whole block. The committed claim: approximately 75% of all former NFL players who died between 2008 and 2023 had CTE, based on statistical modeling that corrects for donation bias. The study, published in JAMA Network Open, examined records from 2,362 deceased former players. Of the 400 whose brains were actually donated and examined, 93.5% showed CTE pathology. The researchers then used those results to model backward across the full population of deceased players, arriving at the 75% estimate. The ladder against prior work is important. An earlier study released in August found at least 25% of former NFL players who died between 2016-2021 had CTE — but that was a floor estimate with less sophisticated bias correction. The general population rate from community brain banks is less than 1%. So this paper's 75% figure sits between the raw donation-sample rate (93.5%) and the earlier conservative estimate (25%), which is exactly where you'd expect a bias-corrected model to land. The architecture here is epidemiological modeling, not neuroscience. The hard science — tau protein accumulation, brain atrophy, the pathological signature of CTE — was already established. What this team built is a statistical bridge from a biased sample (donated brains) to the unobserved population (all deceased players). The average career length in the sample was five years, which matters: these aren't just 15-year veterans. Integrity deserves scrutiny. The 93.5% donation-sample rate is hard data. The 75% population estimate is a model output, and models depend on assumptions about who donates and why. The researchers acknowledge this. The study also flags that CTE pathology doesn't necessarily mean dementia — they estimated 27% of the included players had dementia, a distinct and lower number. That nuance matters and is often lost in headlines. The milestone question is diagnostic tools for living players. Right now, CTE can only be confirmed post-mortem. Yorghos Tripodis, the study's senior author, pointed directly at this: brain bank discoveries have brought researchers "significantly closer to a diagnosis during life." A validated in-vivo CTE diagnostic would transform this from an epidemiological debate into a clinical reality, enabling treatment trials and changing the risk calculus for current players. The obvious successor experiment nobody ran: a prospective cohort study tracking active and recently retired NFL players with longitudinal neuroimaging and cognitive assessments, linked to eventual post-mortem confirmation. The reason it hasn't been done is part logistics (decades-long follow-up), part politics (the NFL's institutional interest in ambiguity), and part consent complexity. The NFL's own statement — focused on "strategies to reduce concussions and head impacts" — signals continued preference for prevention framing over prevalence accountability.
